Impact of Holmium Laser Enucleation of Prostate on Erectile Function: Results of 12 Months Follow-Up

This is the authors' abstract. We don't add key points for this paper.

Objective: To evaluate erectile function in patients with symptomatic benign prostatic hyperplasia (BPH) treated by Holmium laser enucleation of the prostate (HoLEP) operation. Material and Methods:We retrospectively reviewed our recorded data on BPH patients treated by HoLEP between May 2002 - December 2016. 106 patients were enrolled to the study. International Index of Erectile Function-5 (IIEF-5) questionnaires were completed both before the operation and during the follow-up period. First 12 months results on surgical outcome and erectile function after HoLEP were given in this study. Results: A total of 106 patients with a mean age 73.2 ± 4.5 years old were included in this study. The mean volume of the prostate was 77.5 ± 32.3 mL. Mean operative time was 92.6 ± 33.8 min. Total energy which was used during the surgery was 203.5 ± 120 kj. Mean morcelation time was 14.2 ± 11.6 min. Catheterization and hospitalization times were 1.2 ± 0.7 day and 1.1 ± 0.5 day respectively. The mean preoperative IIEF-5 score was 16.5 ± 6. The mean values at 1, 3, 6 months, 12 months were 15.9 ± 3.5, 15.7 ± 4.5, 16.2 ± 2.9, 16.4 ± 3.8, respectively (P >05). There was no significant difference in the mean IIEF-5 scores compared with the preoperative scores during 12 months follow-up period. Conclusion: HoLEP is a safe and effective method of treatment for BPH patients. The short-term surgical outcomes from the point of score on the Turkish version of the International Prostate Symptom Score (IPSS), the maximum flow rate (Qmax) values, and post-voiding residual urine volume (PVR) were excellent. During the 12 months followup period, HoLEP has no negative impact on erectile function with no appreciable decrease on IIEF-5 scores.